MESALAZINE
mesalazine 500 mg modified release tablet, 100
MESALAZINE (13396C)
13396C
Manner of administration:Oral
Restriction
Indication: Ulcerative colitis
Restriction
Indication: Crohn disease
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 4 | Max qty units: 400 | # of repeats: 5 | DPMQ: $238.12 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Pentasa | |||||